MYGN — Myriad Genetics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Myriad Genetics Inc

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$3.85
Market Cap$369M
Float86.0M
Shares Outstanding94.4M
P/E (Forward)54.05
Price/Sales (TTM)0.66
vs. Analyst Target+62.3% to analyst PT
Profit Margin-41.29%
Operating Margin (TTM)-21.41%
Revenue (TTM)$557M
Dividend RateNone
Analyst Target Price$6.25 (15 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $557M -$224M $379M -$123M
2021 $691M -$27.2M $493M $12.3M
2022 $678M -$112M $476M -$84.7M
2023 $753M -$263M $517M -$197M
2024 $838M -$127M $585M -$59.5M
2025 $825M -$366M $577M -$331M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $213M -$331M
Sep 2025 $206M -$27.4M
Dec 2025 $210M -$7.9M
Mar 2026 $200M -$34.1M

Ownership & Float

Insider Ownership3.3%
Institutional Ownership97.7%
Short Float9.2%
% of All Funds Holding2.25%
Number of Funds Holding185

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$4.36Near-term / short-term trend
Weekly40-Week SMA$5.93Medium-term trend
Weekly80-Week SMA$7.50Cyclical trend (business cycle)
Weekly200-Week SMA$15.68Secular trend (multi-year)
Monthly10-Month SMA$5.88Near-term monthly trend
Monthly20-Month SMA$8.19Medium-term monthly trend
Monthly40-Month SMA$14.91Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$4.70 resistance 1.10x 0 months ago
$3.80 support 1.48x 8 months ago
$8.90 resistance 1.64x 12 months ago
$10.80 resistance 1.04x 13 months ago
$12.40 resistance 1.28x 14 months ago

Historical Earnings Reactions (121 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.17% -0.06% 46.28% 34.11% -39.32%
1 Day -1.81% -0.60% 43.80% 46.51% -42.76%
1 Week -1.00% 0.42% 51.24% 51.68% -47.18%
2 Weeks -1.97% -2.20% 43.80% 65.63% -48.24%
1 Month -0.65% -2.45% 45.00% 78.55% -52.10%

Next earnings: July 24, 2026 (57 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan6.5%54.8%31
Feb-1.3%25.8%31
Mar-2.1%48.4%31
Apr-0.1%45.2%31
May0.9%53.3%30
Jun0.5%40.0%30
Jul1.3%53.3%30
Aug1.6%63.3%30
Sep4.4%50.0%30
Oct4.5%56.7%30
Nov2.6%51.6%31
Dec-0.4%48.4%31

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 47.9% 1449
Tuesday 0.09% 49.0% 1583
Wednesday 0.14% 49.6% 1581
Thursday 0.20% 48.8% 1549
Friday 0.06% 50.3% 1544

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 97.7%

Insider Transactions — Smart Summary

Total insider ownership: 3.3%

12-Month Insider Activity Summary

Total Filings3
Net Value+$199,844
Net Shares Change152,007
% of Float0.2%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Phanstiel S. Louise +$494,725.687 1 1 buy
Raha Samraat S. President and CEO +$199,844 1 1 buy
Bisaro Paul +$27,637.5 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-14 Bisaro Paul +$27,637.5 Transaction at $3.69, now +4.5%
2026-03-09 Raha Samraat S. President and CEO +$199,844 Transaction at $5.00, now -22.9%
2026-02-27 Phanstiel S. Louise +$494,725.687 Transaction at $4.73, now -18.7%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Myriad Genetics Inc (MYGN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for MYGN on Trend Edge →